uMed
PrivateLast Round
Series A
Jul 5, 2023
Total Funding Raised
$18.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
uMed is a health and research technology company that provides a platform to automate clinical study processes and connect healthcare providers with research programs.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
uMed Comparables
Compare uMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verana Health | 79% | |
| Paradigm Health | 76% | |
| TriNetX | 76% |
uMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 5, 2023 | ||||
| Seed | Dec 1, 2020 | ||||
| Pre Seed | Oct 8, 2019 |
Key People
Founding team and executive leadership
uMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Playfair Capital | Seed, Series A, Pre Seed |
| Albion Capital | Series A, Seed |
| Delin Ventures | Seed, Series A |
| 11.2 Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 134% MoM, reaching 9.1K.
- Jul 25, 2026
Monthly visitors grew 2274% MoM, reaching 3.9K.
uMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about uMed's valuation, stock price, and market status.
Is uMed a public or private company?
uMed is a private company.
What is the current stock price of uMed?
uMed is a private company with no public stock price. No recent secondary market data is available.
How much is uMed worth (valuation)?
Valuation information for uMed is not publicly available.
Can I buy uMed stock?
uMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was uMed's last funding round?
uMed's most recent funding round was Series A on July 5, 2023.
Who are the main investors in uMed?
Key investors in uMed include Albion Capital.
Will uMed IPO soon?
No public IPO plans have been announced for uMed.
How can I track uMed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor uMed's secondary market activity and sign up for updates.